| Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing R Rabinowitz, D Offen Molecular Therapy 29 (3), 937-948, 2021 | 24 | 2021 |
| CrisPam: SNP-derived PAM analysis tool for allele-specific targeting of genetic variants using CRISPR-Cas systems R Rabinowitz, S Almog, R Darnell, D Offen Frontiers in Genetics 11, 558964, 2020 | 14 | 2020 |
| Towards gene-editing treatment for alzheimer's disease: ApoE4 allele-specific knockout using a CRISPR cas9 variant D Offen, R Rabinowitz, D Michaelson, T Ben-Zur Cytotherapy 20 (5), S18, 2018 | 14 | 2018 |
| The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis Y Volfovitch, AM Tsur, M Gurevitch, D Novick, R Rabinowitz, M Mandel, ... Immunologic Research 70 (6), 817-828, 2022 | 13 | 2022 |
| Prediction of synonymous corrections by the BE-FF computational tool expands the targeting scope of base editing R Rabinowitz, S Abadi, S Almog, D Offen Nucleic acids research 48 (W1), W340-W347, 2020 | 13 | 2020 |
| ApoE4 allele specific knockout using a synthetic Cas9 variant as a potential gene therapy approach for Alzheimer's disease R Rabinowitz, A Kadair, T Ben-Zur, D Michaelson, D Offen Cytotherapy 21 (5), e7, 2019 | 9 | 2019 |
| Computational normal mode analysis accurately replicates the activity and specificity profiles of CRISPR-Cas9 and high-fidelity variants O Shor, R Rabinowitz, D Offen, F Benninger Computational and Structural Biotechnology Journal 20, 2013-2019, 2022 | 4 | 2022 |
| CrisPam–a tool for designing gRNA sequences to specifically target a variant allele using CRISPR R Rabinowitz, R Darnell, D Offen Cytotherapy 21 (5), e6-e7, 2019 | 4 | 2019 |
| Computationally engineered CRISPR-SpyCas9 high-fidelity variants with improved specificity and reduced non-specific DNA damage R Rabinowitz, O Shor, J Zerbib, S Herman, N Zelikson, S Mediwale, ... bioRxiv, 2023.04. 11.536265, 2023 | 1 | 2023 |
| Anti-epileptogenic effect of FC99 and resveratrol O Shor, R Rabinowitz, N Hersh, A Vanichkin, F Benninger Frontiers in Neuroscience 17, 1223196, 2023 | | 2023 |
| Treatment for parkinsonian patients with mutations in the lrrk2 gene D Offen, R Rabinowitz US Patent App. 16/769,260, 2020 | | 2020 |
| Compositions and methods specifically targeting the apolipoprotein e4 (apoe4) and uses thereof in apoe4 associated conditions D Offen, R Rabinowitz, BENZUR Tall, D Michaelson US Patent App. 16/498,993, 2020 | | 2020 |
Daniel OffenTel Aviv UniversityVerified email at post.tau.ac.il
